Sanofi | SNY - Pre Tax Profit




Sanofi reported $4.96B in Pre-Tax Profit for its fiscal quarter ending in September of 2024.

Pre Tax Profit Change Date
AbbVie USD 4.81B 2.73B Dec/2024
Amgen USD 782M 2.32B Dec/2024
AstraZeneca USD 1.67B 162M Dec/2024
Bristol-Myers Squibb USD 175M 1.5B Dec/2024
Canopy Growth CAD -131248000 8.25M Sep/2024
Corcept Therapeutics USD 52.94M 11.35M Sep/2024
Drreddys Laboratories 19.17B 353M Sep/2024
Eli Lilly USD 5.04B 3.45B Dec/2024
Galapagos EUR 19.03M 68.17M Dec/2024
Genmab DKK 3.6B 1.88B Dec/2024
GlaxoSmithKline GBP 563M 2.08B Dec/2024
Glaxosmithkline USD 64M 2.92B Sep/2024
J&J USD 3.89B 3.39B Dec/2024
Merck USD 4.17B 80M Dec/2024
Novartis USD 4.66B 269M Dec/2024
Novartis USD 3.38B 1.38B Sep/2024
Pacira USD -138856000 175.44M Sep/2024
Perrigo USD 139.4M 213.4M Sep/2024
Pfizer USD -10000000 4.73B Dec/2024
Prestige Brands USD 80.15M 8.49M Dec/2024
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 2.18B 1.33B Dec/2024
Sanofi USD 4.96B 2.05B Sep/2024
Supernus Pharmaceuticals USD 44.94M 18.64M Sep/2024
UCB EUR 123M 464.07M Jun/2024
Zoetis USD 3.13B 2.26B Dec/2024